Juan-Juan Huang Selected Research

Neurodegeneration with brain iron accumulation (NBIA)

1/2019

Impaired iPLA2β activity affects iron uptake and storage without iron accumulation: An in vitro study excluding decreased iPLA2β activity as the cause of iron deposition in PLAN.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan-Juan Huang Research Topics

Disease

2	COVID-19 01/2022 - 01/2021
2	Neoplasms (Cancer) 06/2021 - 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020
1	Multiple Myeloma 01/2020
1	Neurodegeneration with brain iron accumulation (NBIA) 01/2019
1	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 01/2019

Drug/Important Bio-Agent (IBA)

1	VaccinesIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 06/2021
1	recombinant interferon alpha 2b-like proteinIBA 01/2021
1	Lopinavir FDA Link 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	CaspasesIBA 01/2020
1	UbiquitinIBA 01/2020
1	Proteasome InhibitorsIBA 01/2020
1	marizomibIBA 01/2020
1	carfilzomibIBA 01/2020
1	delanzomibIBA 01/2020
1	ixazomibIBA 01/2020
1	ONX 0912IBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 01/2020
1	Phospholipases (Phospholipase)IBA 01/2019

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020